1 | the natural health industry | | | | | | | 3 | 0.40% |
2 | natural health industry and | | | | | | | 2 | 0.27% |
3 | products cannot be digested | | | | | | | 1 | 0.13% |
4 | wrong with recommended medical | | | | | | | 1 | 0.13% |
5 | moreover they do not | | | | | | | 1 | 0.13% |
6 | assimilated moreover they do | | | | | | | 1 | 0.13% |
7 | be assimilated moreover they | | | | | | | 1 | 0.13% |
8 | cannot be assimilated moreover | | | | | | | 1 | 0.13% |
9 | therefore cannot be assimilated | | | | | | | 1 | 0.13% |
10 | and therefore cannot be | | | | | | | 1 | 0.13% |
11 | body and therefore cannot | | | | | | | 1 | 0.13% |
12 | human body and therefore | | | | | | | 1 | 0.13% |
13 | with recommended medical treatments? | | | | | | | 1 | 0.13% |
14 | be digested by the | | | | | | | 1 | 0.13% |
15 | cannot be digested by | | | | | | | 1 | 0.13% |
16 | and thus cannot find | | | | | | | 1 | 0.13% |
17 | these products cannot be | | | | | | | 1 | 0.13% |
18 | is still wrong with | | | | | | | 1 | 0.13% |
19 | consequently these products cannot | | | | | | | 1 | 0.13% |
20 | etc consequently these products | | | | | | | 1 | 0.13% |
21 | products etc consequently these | | | | | | | 1 | 0.13% |
22 | the kids are not | | | | | | | 1 | 0.13% |
23 | kids are not alright | | | | | | | 1 | 0.13% |
24 | tar bitumen gelatin waste | | | | | | | 1 | 0.13% |
25 | coal tar bitumen gelatin | | | | | | | 1 | 0.13% |
26 | binders coal tar bitumen | | | | | | | 1 | 0.13% |
27 | fillers binders coal tar | | | | | | | 1 | 0.13% |
28 | preservatives fillers binders coal | | | | | | | 1 | 0.13% |
29 | harmful substances for example | | | | | | | 1 | 0.13% |
30 | contain harmful substances for | | | | | | | 1 | 0.13% |
31 | still wrong with recommended | | | | | | | 1 | 0.13% |
32 | have a synergism due | | | | | | | 1 | 0.13% |
33 | these products contain harmful | | | | | | | 1 | 0.13% |
34 | lodged in the tissues | | | | | | | 1 | 0.13% |
35 | by pharmaceutical and food | | | | | | | 1 | 0.13% |
36 | manufactured by pharmaceutical and | | | | | | | 1 | 0.13% |
37 | are manufactured by pharmaceutical | | | | | | | 1 | 0.13% |
38 | present diseases multi complexes | | | | | | | 1 | 0.13% |
39 | enhancing present diseases multi | | | | | | | 1 | 0.13% |
40 | or enhancing present diseases | | | | | | | 1 | 0.13% |